AORTIC WALL HYPERTROPHY

This adverse event was reported 41 times

AORTIC WALL HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM 15 0.0013
1 PROPYLTHIOURACIL 2 0.0010
2 FENFLURAMINE 2 0.0004
3 LEMBOREXANT 1 0.0003
4 SCOPOLAMINE 1 0.0003
5 LEVOCARNITINE 1 0.0003
6 LEVOLEUCOVORIN 1 0.0003
7 PONATINIB HYDROCHLORIDE 1 0.0002
8 PALONOSETRON HYDROCHLORIDE 1 0.0002
9 TASIMELTEON 1 0.0002
See all drugs enriched for association with AORTIC WALL HYPERTROPHY